about
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizerHuman pontine glioma cells can induce murine tumors.Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture.Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes.Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma.Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.Role of CYB5A in pancreatic cancer prognosis and autophagy modulationmiR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastomaOptical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment.WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas.Development of atopic dermatitis in mice transgenic for human apolipoprotein C1.Three-dimensional histochemistry and imaging of human gingiva.Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden miceCombined therapy of AXL and HDAC inhibition reverses mesenchymal transition in diffuse intrinsic pontine gliomaA cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
P50
Q28822232-5689ABF2-D634-49CC-8040-A2241086B051Q34054150-9D663E92-A872-438A-B7F4-8541139B1A92Q34291274-5BAAF501-979D-4994-85CE-5ABD84330DF0Q34505311-A8F7C089-92DE-494F-8FA5-200A4A60BBD7Q35004346-FE23D876-70A5-480D-BA90-96E0ECC9F89BQ37141510-5392ECC6-B710-4C0D-891E-6288144550B9Q37532658-E6ACAA90-2380-47AB-8599-A0B34471F0D7Q39966525-40D11AA6-58F6-42DF-8314-003E8EA68A72Q41547370-CEAB05C2-0A9B-4CF0-BD61-FE1E0DB9932BQ42611574-762B1436-6037-45FC-A7DF-1E13BB4052BEQ44183928-F4045C24-87E9-460E-ACE4-B2E746787DC8Q46873973-C0E4BA53-AF48-4C63-AACC-CB4894D0CDEDQ48158051-FE152B3D-28BD-4CF5-971F-E637D0961486Q48508934-A117A8B6-FFB1-47B7-B1DC-EB907E6B0B34Q52562611-82CD9DFE-C247-4D45-A0ED-43296562DEEFQ52715827-D02AA5E3-A25B-4582-A7CB-2BF80C07C554Q54334419-7CB8156E-EB1F-48E9-916D-BEDEBBC8ED0AQ56999050-3E6DA73F-EA64-44D6-A4AB-EB4E53E7FB5FQ90280358-A749A72E-56C9-4DB4-930D-04B3F69F8264Q96303348-8D4435A1-CFA5-4996-82BF-F94D9923937D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tonny Lagerweij
@ast
Tonny Lagerweij
@en
Tonny Lagerweij
@es
Tonny Lagerweij
@nl
Tonny Lagerweij
@sl
type
label
Tonny Lagerweij
@ast
Tonny Lagerweij
@en
Tonny Lagerweij
@es
Tonny Lagerweij
@nl
Tonny Lagerweij
@sl
prefLabel
Tonny Lagerweij
@ast
Tonny Lagerweij
@en
Tonny Lagerweij
@es
Tonny Lagerweij
@nl
Tonny Lagerweij
@sl
P106
P31
P496
0000-0003-1043-7452